Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The latest news, stories and exciting findings from across the Oxford cancer research community

University's RadCam library highlighted in yellow

Yellowstone Biosciences spinout launches to advance cutting-edge cancer therapies

Yellowstone Biosciences, a biotechnology spinout, has launched to pioneer new cancer treatments using advanced T-cell therapies based on ground-breaking research from the MRC Weatherall Institute of Molecular Medicine at University of Oxford.

Oxford success in the 2024 Lasker Essay Contest

Subashan Vadibeler, a recent Oxford Rhodes scholar and MRes student, is one of five co-winners of our international 2024 Essay Contest sponsored by the Lasker Foundation.

OCION: In conversation with Felipe Galvez-Cancino

Through the Oxford Cancer Immuno-Oncology Network (OCION), we aim to apply Oxford's leading expertise in fundamental immunology to enable more patients, with a wide range of cancer types, to benefit safely from tailored immunotherapy use. We sat down with Professor Felipe Galvez-Cancino, who has recently joined the Nuffield Department of Medicine, to discuss his research.

GambitBio: empowering early detection at home

GambitBio is developing an at-home lateral flow test to screen for the most common cancers, empowering people to take control of their health and reduce the number of cancer-related deaths. CRUK recently interviewed CEO, Tiffany Ma, who co-founded the venture while completing her DPhil at the University of Oxford.

Professor Freddie Hamdy recognised in the King's Birthday Honours 2024

Professor Freddie Hamdy, Nuffield Professor of Surgery and Head of the Nuffield Department of Surgical Sciences, has been appointed Commander of the Order of the British Empire (CBE) in the King's Birthday Honours 2024. The honour recognises his services to Surgical and Cancer Sciences.

OCION: In conversation with Dave Withers

Through the Oxford Cancer Immuno-Oncology Network (OCION), we aim to apply Oxford's leading expertise in fundamental immunology to enable more patients, with a wide range of cancer types, to benefit safely from tailored immunotherapy use. We sat down with Professor David Withers, who recently moved to Oxford, to discuss his research.

Immunotherapy: finding hidden ways to treat cancer

Giamp Valenzano, a DPhil in Cancer Science student, joins forces with Oxford Sparks to deliver a video explaining how his research on immunotherapy aims to help treat cancer

Oxford Cancer to host information evening for people affected by liver cancer

Those affected by liver cancer are invited to an online information evening with our liver cancer experts. The event is due to take place on Thursday 3rd of October, between 5 – 7 pm.

Glowing dye helps surgeons eradicate prostate cancer

A glowing marker dye that sticks to prostate cancer cells could help surgeons to remove them in real-time, according to a study funded by Cancer Research UK.

Oxford Cancer Immuno-Oncology Network 2024 Symposium

Fantastic day of immuno-oncology talks and networking at this years' annual OCION Symposium!

OCION 2024 Funding Scheme is live!

The 2024 Oxford Cancer Immuno-Oncology Network (OCION) Funding Scheme is now open!

Launch of the Oxford Translational Data Platform

The Oxford Cancer Centre and the Oxford ECMC are launching a new data initiative to maximize the discovery potential of samples and information collected during clinical trials.

Prof Anindita Roy awarded CRUK funding to study infant acute lymphoblastic leukaemia

Congratulations to Professor Anindita Roy who successfully applied for a CRUK Data4CYP award!

Oxford Cancer: 5 minutes with Professor Dame Molly Stevens

Professor Dame Molly Stevens is John Black Professor of Bionanoscience in the Department of Physiology, Anatomy and Genetics and the Institute of Biomedical Engineering. She recently moved her lab from Imperial College London to the University of Oxford and the Kavli Institute for nanoscience discovery, and she is joining the Oxford Cancer community.

Oxford Cancer researchers elected as Fellows of the Academy of Medical Sciences

The Academy of Medical Sciences has elected four Oxford Cancer biomedical and health scientists to its fellowship in 2024.

Oxford Cancer Professor Yang Shi honoured by the Royal Society

Ludwig Oxford Professor Yang Shi has been elected as a Fellow of the Royal Society for his contributions to epigenetics research.

Blood proteins may be able to predict risk of cancer more than seven years before it is diagnosed

Proteins linked to cancer can start appearing in people’s blood more than seven years before they’re diagnosed. In the future, it’s possible doctors could use these early warning signs to find and treat cancer much earlier than they’re able to today.

OCION Funding Scheme: In conversation with David Church and Luciana Gneo

The mission of the Oxford Cancer Immuno-Oncology Network (OCION) Funding Scheme is to pump-prime innovative Oxford-based immuno-oncology research and build capacity in cancer immunology. We sat down with 2023 awardees, David Church and Luciana Gneo, to discuss what research the fund will enable them to carry out.

Researchers develop new way to identify people with new-onset diabetes who are at risk of pancreatic cancer

The new method could help people with new-onset diabetes at high-risk of developing pancreatic cancer to be identified more accurately so that they can be monitored.

Immune cells hunt down cancer around the body – discovery could lead to personalised treatments for advanced breast cancer

Scientists have discovered the key features of immune B cells which make them successful at targeting tumours – including when cancer has spread to a different part of the body.

Load More